Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Insomnia01:27

Insomnia

Insomnia is a prevalent sleep disorder characterized by difficulty falling asleep, frequent awakenings during the night, and waking up too early without being able to return to sleep. People with insomnia often experience these disruptions at least three nights a week for at least one month. Chronic insomnia, which lasts for at least three months, can lead to increased anxiety, which in turn can worsen sleep difficulties, creating a cycle of sleeplessness and stress.
Multiple factors contribute...
Management of Insomnia01:19

Management of Insomnia

The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
Blind Procedures02:07

Blind Procedures

Ideally, the people who observe and record the children’s behavior are unaware of who was assigned to the experimental or control group, in order to control for experimenter bias. Experimenter bias refers to the possibility that a researcher’s expectations might skew the results of the study. Remember, conducting an experiment requires a lot of planning, and the people involved in the research project have a vested interest in supporting their hypotheses. If the observers knew which child was...
Sedatives and Hypnotics Drugs: Miscellaneous Agents01:17

Sedatives and Hypnotics Drugs: Miscellaneous Agents

Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Substance Use Disorders Affecting Sleep01:24

Substance Use Disorders Affecting Sleep

Substance use disorders involve a pattern of using drugs more extensively than intended and continuing use despite harmful consequences. This includes legal substances like alcohol and nicotine, as well as illegal drugs. These disorders often involve both physical and psychological dependence, reflecting compulsive use of substances that significantly alter thoughts, feelings, and behaviors, contributing to a major public health issue.
Understanding the concepts of physical dependence,...
The Placebo Effect01:54

The Placebo Effect

The placebo effect occurs when people's expectations or beliefs influence or determine their experience in a given situation. In other words, simply expecting something to happen can actually make it happen.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Medication discontinuation in the era of elexacaftor/tezacaftor/ivacaftor: an Australian survey and qualitative interview.

Internal medicine journal·2026
Same author

Drawing insights: Developing a humanistic understanding of asthma through reflective artmaking among pharmacy and nursing students.

Currents in pharmacy teaching & learning·2026
Same author

Safer use of short-acting beta<sub>2</sub>-agonists: perceiving and responding to risk-a qualitative study.

The Journal of asthma : official journal of the Association for the Care of Asthma·2026
Same author

Cannabinol for Acute Treatment of Insomnia Disorder in a Randomized Placebo-Controlled Crossover Trial.

Journal of sleep research·2026
Same author

An evaluation of cultural safety education in a pharmacy curriculum through constructive alignment mapping.

Currents in pharmacy teaching & learning·2026
Same author

Attributes and levels in discrete choice experiments for pharmacy services: A systematic review to inform asthma intervention design.

Exploratory research in clinical and social pharmacy·2026

Related Experiment Video

Updated: May 13, 2026

Meta-Analysis of the Effectiveness and Safety of Shugan Jieyu Capsules for the Treatment of Insomnia
04:34

Meta-Analysis of the Effectiveness and Safety of Shugan Jieyu Capsules for the Treatment of Insomnia

Published on: February 17, 2023

Insomnia patients' help-seeking experiences.

Janet M Y Cheung1, Delwyn J Bartlett, Carol L Armour

  • 1a Faculty of Pharmacy , The University of Sydney , Australia.

Behavioral Sleep Medicine
|March 22, 2013
PubMed
Summary
This summary is machine-generated.

Insomnia patients seek medical help when daytime symptoms arise. However, limited awareness, access, and high costs hinder the use of cognitive behavioral therapy for insomnia (CBT-I).

More Related Videos

Heat-sensitive Moxibustion as a Traditional Chinese Medicine Therapy for Chronic Obstructive Pulmonary Disease Combined with Insomnia
04:59

Heat-sensitive Moxibustion as a Traditional Chinese Medicine Therapy for Chronic Obstructive Pulmonary Disease Combined with Insomnia

Published on: May 30, 2025

Association Between Sleep Quality and Cognitive Symptoms in Patients with Major Depressive Disorder
04:33

Association Between Sleep Quality and Cognitive Symptoms in Patients with Major Depressive Disorder

Published on: April 26, 2024

Related Experiment Videos

Last Updated: May 13, 2026

Meta-Analysis of the Effectiveness and Safety of Shugan Jieyu Capsules for the Treatment of Insomnia
04:34

Meta-Analysis of the Effectiveness and Safety of Shugan Jieyu Capsules for the Treatment of Insomnia

Published on: February 17, 2023

Heat-sensitive Moxibustion as a Traditional Chinese Medicine Therapy for Chronic Obstructive Pulmonary Disease Combined with Insomnia
04:59

Heat-sensitive Moxibustion as a Traditional Chinese Medicine Therapy for Chronic Obstructive Pulmonary Disease Combined with Insomnia

Published on: May 30, 2025

Association Between Sleep Quality and Cognitive Symptoms in Patients with Major Depressive Disorder
04:33

Association Between Sleep Quality and Cognitive Symptoms in Patients with Major Depressive Disorder

Published on: April 26, 2024

Area of Science:

  • Sleep Medicine
  • Health Services Research

Background:

  • Effective insomnia management relies on timely access to appropriate treatment.
  • Understanding patient experiences in accessing healthcare for insomnia is limited.

Purpose of the Study:

  • To explore the help-seeking experiences and behavioral patterns of insomnia patients accessing specialist care.
  • To identify barriers to accessing and engaging with insomnia treatments.

Main Methods:

  • Purposive sampling of 26 insomnia patients from specialist sleep and mental health clinics in New South Wales, Australia.
  • Data collection via questionnaires and in-depth semi-structured interviews.
  • Framework analysis of transcribed interview data.

Main Results:

  • Daytime symptoms of insomnia are key triggers for patients seeking medical help.
  • Key themes identified include patients' sleep beliefs, treatment beliefs, and access to specialized care.
  • Barriers to cognitive behavioral therapy for insomnia (CBT-I) include low awareness, poor referral pathways, limited providers, and high costs.

Conclusions:

  • Patient illness perception, particularly daytime symptoms, drives help-seeking behavior for insomnia.
  • Significant obstacles impede the broader adoption of CBT-I, necessitating systemic improvements in awareness, accessibility, and affordability.